Loading clinical trials...
Loading clinical trials...
.Neurofibromatosis type 2 is an inherently autosomal dominant genetic disease, but cases of mosaicism or de novo mutation are not uncommon. the prevalence is estimated at 1 / 60,000. the clinical pres...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire de Nice
NCT06724627 · Skin Condition, Dermatology, and more
NCT03079999 · Vestibular Schwannoma, Acoustic Neuroma, and more
NCT03406208 · Neurofibromatoses, Neurofibromatosis 1, and more
NCT05685836 · Neurofibromatosis 2
NCT04890132 · Vestibular Schwannoma, Inner Ear Disease, and more
Nice Hospital
Nice
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions